Uncategorized
Clearside Biomedical, Inc. to Report Efficacy and Safety Results in Non-infectious Uveitis Using a Single Suprachoroidal Injection of Triamcinolone Acetonide at 2015 ARVO Meeting
ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical, which develops drug therapies to treat eye diseases, will present its Phase 1/2 clinical trial results May 5 at the Association for Research and Vision in Ophthalmology meeting.
